In January 2003, the immunophenotype analysis of peripheral blood revealed a second clonal B-cell population consisting of cells with kappa light chains that were CD5+ CD23+, consistent with CLL as opposed to the original lambda CD5+ CD23− clone, which was not detected at this evaluation. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.